MNC Land Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? MNC Land Tbk. trades at Rp79 (market cap 9.12T, 2.15B 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: MNC Land Tbk. is far larger — about 87.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KPIG | SCPI | |
|---|---|---|
Market Cap | 9.12T | 104.4B |
Volume | 2.15B | — |
Lot | 21.49M | — |
Turnover | 173.67B | — |
Average Price | 80.82 | — |
Value | 173.67B | — |
Indicative Equilibrium Price | 79 | — |
Indicative Equilibrium Volume | 116.99K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT MNC Land Tbk, formerly PT Global Land Development Tbk ( PT Kridaperdana Indahgraha Tbk ) was established based on Notarial Deed No. 65 dated June 11, 1990 of Achmad Fatimah, S.H., a substitute notary of Imas Fatimah, S.H., notary in Jakarta as amended by deed No. 72 dated October 19, 1990 of Imas Fatimah, S.H., notary in Jakarta. Subsequently, the notarial deed was amended by deed No. 129 dated June 26, 1991 of Achmad Bajumi, S.H., substitute notary of Imas Fatimah, S.H., notary in Jakarta.
Read more on KPIG →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →